1. Home
  2. BNTC vs SUIG Comparison

BNTC vs SUIG Comparison

Compare BNTC & SUIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • SUIG
  • Stock Information
  • Founded
  • BNTC 1995
  • SUIG 2006
  • Country
  • BNTC United States
  • SUIG United States
  • Employees
  • BNTC N/A
  • SUIG N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • SUIG Finance Companies
  • Sector
  • BNTC Health Care
  • SUIG Finance
  • Exchange
  • BNTC Nasdaq
  • SUIG Nasdaq
  • Market Cap
  • BNTC 365.1M
  • SUIG 321.6M
  • IPO Year
  • BNTC N/A
  • SUIG N/A
  • Fundamental
  • Price
  • BNTC $13.90
  • SUIG $4.27
  • Analyst Decision
  • BNTC Strong Buy
  • SUIG
  • Analyst Count
  • BNTC 5
  • SUIG 0
  • Target Price
  • BNTC $24.80
  • SUIG N/A
  • AVG Volume (30 Days)
  • BNTC 40.3K
  • SUIG 2.0M
  • Earning Date
  • BNTC 11-13-2025
  • SUIG 11-11-2025
  • Dividend Yield
  • BNTC N/A
  • SUIG N/A
  • EPS Growth
  • BNTC N/A
  • SUIG 619.34
  • EPS
  • BNTC N/A
  • SUIG 0.24
  • Revenue
  • BNTC N/A
  • SUIG $3,305,884.00
  • Revenue This Year
  • BNTC N/A
  • SUIG N/A
  • Revenue Next Year
  • BNTC N/A
  • SUIG N/A
  • P/E Ratio
  • BNTC N/A
  • SUIG $19.31
  • Revenue Growth
  • BNTC N/A
  • SUIG 1.77
  • 52 Week Low
  • BNTC $9.09
  • SUIG $1.13
  • 52 Week High
  • BNTC $17.15
  • SUIG $8.66
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 54.74
  • SUIG N/A
  • Support Level
  • BNTC $13.49
  • SUIG N/A
  • Resistance Level
  • BNTC $14.01
  • SUIG N/A
  • Average True Range (ATR)
  • BNTC 0.54
  • SUIG 0.00
  • MACD
  • BNTC -0.04
  • SUIG 0.00
  • Stochastic Oscillator
  • BNTC 64.70
  • SUIG 0.00

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About SUIG Sui Group Holdings Limited Common Stock

Sui Group Holdings Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.

Share on Social Networks: